The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer.
Ohnmacht AJ, Stahler A, Stintzing S, Modest DP, Holch JW, Westphalen CB, Hölzel L, Schübel MK, Galhoz A, Farnoud A, Ud-Dean M, Vehling-Kaiser U, Decker T, Moehler M, Heinig M, Heinemann V, Menden MP.
Ohnmacht AJ, et al. Among authors: vehling kaiser u.
Nat Commun. 2023 Sep 4;14(1):5391. doi: 10.1038/s41467-023-41011-4.
Nat Commun. 2023.
PMID: 37666855
Free PMC article.